These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7628765)

  • 1. Autoimmune antiphospholipid antibodies: what is their true target?
    Pengo V; Biasiolo A; Fior MG
    Haematologica; 1995; 80(2 Suppl):127-30. PubMed ID: 7628765
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiphospholipid antibodies: involvement of protein cofactors.
    Galli M; Barbui T; Zwaal RF; Comfurius P; Bevers EM
    Haematologica; 1993; 78(1):1-4. PubMed ID: 8491417
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism.
    Hirmerova J; Ulcova-Gallova Z; Seidlerova J; Filipovsky J; Bibkova K; Micanova Z; Mayer O
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):318-25. PubMed ID: 19221100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies.
    Gharavi AE; Sammaritano LR; Bovastro JL; Wilson WA
    J Lab Clin Med; 1995 Jun; 125(6):775-8. PubMed ID: 7769372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction].
    Forastiero RR; Martinuzzo ME; Carreras LO
    Sangre (Barc); 1999 Jun; 44(3):223-30. PubMed ID: 10481585
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
    Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
    Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
    Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ
    Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in beta 2-glycoprotein I antigenicity induced by phospholipid binding.
    Wagenknecht DR; McIntyre JA
    Thromb Haemost; 1993 Apr; 69(4):361-5. PubMed ID: 7684533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-beta2-glycoprotein I antibodies.
    Tsutsumi A; Ichikawa K; Matsuura E; Koike T
    Lupus; 1998; 7 Suppl 2():S98-102. PubMed ID: 9814683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies.
    Schlame M; Haller I; Sammaritano LR; Blanck TJ
    Thromb Haemost; 2001 Dec; 86(6):1475-82. PubMed ID: 11776316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of antiphospholipid antibodies.
    de Groot PG; Derksen RH
    Neth J Med; 2004 Sep; 62(8):267-72. PubMed ID: 15588066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent findings on antigens reactive to antiphospholipid antibodies].
    Matsuda S
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Feb; 19(1):27-38. PubMed ID: 8681025
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid cofactor.
    Gharavi AE
    Stroke; 1992 Feb; 23(2 Suppl):I7-10. PubMed ID: 1561674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice.
    Blank M; Faden D; Tincani A; Kopolovic J; Goldberg I; Gilburd B; Allegri F; Balestrieri G; Valesini G; Shoenfeld Y
    J Autoimmun; 1994 Aug; 7(4):441-55. PubMed ID: 7980847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of the antiphospholipid syndrome.
    Greaves M; Hill MB; Phipps J; Hughes P; Ford I
    Thromb Haemost; 1996 Nov; 76(5):817-8. PubMed ID: 8950799
    [No Abstract]   [Full Text] [Related]  

  • 19. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor.
    Valesini G; Shoenfeld Y
    Autoimmunity; 1992; 14(2):105-10. PubMed ID: 1303677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.